The Quality of Antimalarials - A Study in Selected African Countries - EDM Research Series No. 030
(2003; 67 pages) Voir le document au format PDF
Table des matières
Afficher le documentAuthors
Afficher le documentCountry Research Team Leaders
Afficher le documentLaboratory Support
Afficher le documentAcknowledgements
Afficher le documentAcronyms
Afficher le documentExecutive summary
Afficher le document1. Background
Ouvrir ce répertoire et afficher son contenu2. Methodology
Afficher le document3. Results
Ouvrir ce répertoire et afficher son contenu4. Discussion
Ouvrir ce répertoire et afficher son contenu5. Conclusions and recommendations
Afficher le documentReferences
Ouvrir ce répertoire et afficher son contenuTables
Fermer ce répertoireAnnexes
Afficher le documentANNEX: 1A
Afficher le documentANNEX: 1B
Afficher le documentANNEX: 1C
Afficher le documentANNEX: 2A
Afficher le documentANNEX: 2B
Afficher le documentANNEX: 2C
Afficher le documentANNEX: 3A
Afficher le documentANNEX: 3B
Afficher le documentANNEX: 3C
Afficher le documentANNEX: 4A
Afficher le documentANNEX: 4B
Afficher le documentANNEX: 4C
Afficher le documentANNEX: 5A
Afficher le documentANNEX: 5B
Afficher le documentANNEX: 5C
Afficher le documentANNEX: 6A
Afficher le documentANNEX: 6B
Afficher le documentANNEX: 6C
Afficher le documentANNEX: 7A
Afficher le documentANNEX: 7B
Afficher le documentANNEX: 7C
Afficher le documentOther documents in the EDM Research Series
Afficher le documentEDM Research Series No. 30
 

ANNEX: 6C

Country: Sudan
Product: Sulphadoxine/pyrimethamine tablets

 

CENQAM LAB RESULTS

       

Dissolution test

Active ingredient content

CENQAM
REF NO

Sample
number

CP

Manufacturer

Mean
dissolution

%
RSD
(n=6)

Low
fail
<65%

Pass
>65%

1st
value

2nd
value

3rd
value

Mean
value

Low
fail
<90%

High
fail
>110%

Pass
90 -110%

20020543-P

SU/SPT/TH01

TH

Lyka

43.91

2.07

43.91

-

95.38

96.74

97.10

96.41

-

-

96.41

20020543-S

SU/SPT/TH01

TH

Lyka

87.59

1.47

-

87.59

98.18

97.31

98.50

98.00

-

-

98.00

20020544-P

SU/SPT/DH02

D

General Medicine

18.79

10.06

18.79

-

-

94.55

98.49

96.52

-

-

96.52

20020544-S

SU/SPT/DH02

D

General Medicine

93.54

2.81

-

93.54

-

98.22

96.81

97.52

-

-

97.52

20020545-P

SU/SPT/DS03

DMS

IPCA

73.86

1.12

-

73.86

95.74

96.47

96.86

96.36

-

-

96.36

20020545-S

SU/SPT/DS03

DMS

IPCA

92.94

1.71

-

92.94

93.60

97.48

95.02

95.37

-

-

95.37

20020546-P

SU/SPT/CS04

CMS

General Medicine

12.74

14.49

12.74

-

91.04

97.48

93.85

94.12

-

-

94.12

20020546-S

SU/SPT/CS04

CMS

General Medicine

95.32

1.83

-

95.32

96.94

99.63

97.64

98.07

-

-

98.07

20020547-P

SU/SPT/HC05

HC

IPCA

52.46

6.77

52.46

-

98.79

98.60

99.25

98.88

-

-

98.88

20020547-S

SU/SPT/HC05

HC

IPCA

87.68

1.70

-

87.68

97.12

97.17

97.89

97.39

-

-

97.39

20020548-P

SU/SPT/PH06

P

Roche

46.47

3.46

46.47

-

103.22

108.64

103.36

105.07

-

-

105.07

20020548-S

SU/SPT/PH06

P

Efroze

95.10

0.49

-

95.10

100.44

103.48

97.10

100.34

-

-

100.34

20020549-P

SU/SPT/PH07

P

Efroze

9.74

19.31

9.74

-

107.44

104.84

103.59

105.29

-

-

105.29

20020549-S

SU/SPT/PH07

P

Efroze

83.17

5.76

-

83.17

97.03

91.94

94.17

94.38

-

-

94.38

20020550-P

SU/SPT/PH08

P

Elie

50.88

4.11

50.88

-

95.66

97.25

97.72

96.88

-

-

96.88

20020550-S

SU/SPT/PH08

P

Elie

95.69

1.88

-

95.69

95.47

96.87

96.73

96.36

-

-

96.36

20020551-P

SU/SPT/SH09

S

Amipharma

14.90

1.77

14.90

-

99.03

98.59

98.30

98.64

-

-

98.64

20020551-S

SU/SPT/SH09

S

Amipharma

95.18

0.88

-

95.18

100.33

100.27

99.85

100.15

-

-

100.15

20020552-P

SU/SPT/SH10

S

General Medicine

19.10

7.31

19.10

-

105.21

98.73

104.05

102.66

-

-

102.66

20020552-S

SU/SPT/SH10

S

General Medicine

99.21

4.44

-

99.21

101.56

95.73

100.61

99.30

-

-

99.30

20020553-P

SU/SPT/SH11

S

Amipharma

15.45

13.81

15.45

-

99.57

95.99

96.83

97.46

-

-

97.46

20020553-S

SU/SPT/SH11

S

Amipharma

103.75

3.52

-

103.75

101.39

97.90

99.36

99.55

-

-

99.55

20020554-P

SU/SPT/VE12

V

IPCA

58.92

2.92

58.92

-

96.42

97.37

102.11

98.63

-

-

98.63

20020554-S

SU/SPT/VE12

V

IPCA

83.30

4.53

-

83.30

96.74

95.62

-

96.18

-

-

96.18

20020555-P

SU/SPT/VE13

V

Not known

66.26

8.04

-

66.26

102.65

103.37

107.35

104.46

-

-

104.46

20020555-S

SU/SPT/VE13

V

Not known

92.89

11.06

-

92.89

101.83

102.71

103.07

102.54

-

-

102.54

20020556-P

SU/SPT/VE14

V

IPCA

72.08

1.03

-

72.08

99.08

100.48

101.00

100.19

-

-

100.19

20020556-S

SU/SPT/VE14

V

IPCA

97.40

1.31

-

97.40

100.56

101.44

101.91

101.30

-

-

101.30

20020557-P

SU/SPT/VE15

V

Amipharma

15.76

10.81

15.76

-

101.58

102.22

106.94

103.58

-

-

103.58

20020557-S

SU/SPT/VE15

V

Amipharma

99.77

0.79

-

99.77

102.74

102.11

105.59

103.48

-

-

103.48

20020558-P

SU/SPT/HH16

H

Not known

NS

-

-

-

99.16

-

-

-

-

-

99.16

20020558-S

SU/SPT/HH16

H

Not known

NS

-

-

-

100.86

-

-

-

-

-

100.86

20020559-P

SU/SPT/HH17

H

Not known

NS

-

-

-

99.24

-

-

-

-

-

99.24

20020559-S

SU/SPT/HH17

H

Not known

NS

-

-

-

103.21

-

-

-

-

-

103.21

20020560-P

SU/SPT/HH18

H

Not known

NS

-

-

-

100.90

99.85

-

100.37

-

-

100.37

20020560-S

SU/SPT/HH18

H

Not known

NS

-

-

-

101.96

101.21

-

101.59

-

-

101.59

20020561-P

SU/SPT/HH19

H

Not known

NS

-

-

-

101.44

100.96

-

101.20

-

-

101.20

20020561-S

SU/SPT/HH19

H

Not known

NS

-

-

-

102.28

101.65

-

101.96

-

-

101.96

20020562-P

SU/SPT/HH20

H

Not known

NS

-

-

-

104.05

102.12

-

103.08

-

-

103.08

20020562-S

SU/SPT/HH20

H

Not known

NS

-

-

-

104.09

102.30

-

103.19

-

-

103.19

REF NO: Reference number

RSD: Related standard deviation

CP: Collection point

   

CMS: Central medical stores

DH: District hospital

DMS: District medical stores

   

H: Household

HC: Health centre

P: Pharmacy

S: Shop

V: Vendor

TH: Teaching hospital

P: Pyrimethamine

S: Sulphadoxine

NS: Not enough tablets received to perform dissolution test

 
vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 29 octobre 2018